Cambridge, Massachusetts-based AlloVir Inc. is scheduled to go public on the Nasdaq Global Select Market under the symbol "ALVR" on July 30, 2020. Founded in 2013, AlloVir is a late clinical-stage cell therapy company developing allogeneic T cell therapies to treat devastating viral diseases.
from RTT - Biotech https://ift.tt/2CX07dd
via IFTTT
No comments:
Post a Comment